Conditions: Overactive Bladder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 951
Healthy volunteers: no

Brief summary:
To evaluate the efficacy and safety of fesoterodine in comparison to placebo for overactive bladder.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: fesoterodine fumarate intervention 2: Placebo intervention 3: fesoterodine fumarate
Intervention descriptions: intervention 1: 8mg tablets OD for 12 weeks intervention 2: Corresponding placebo tablets OD for 12 weeks intervention 3: 4mg tablets OD for 12 weeks

Protocol document: